Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers
{{output}}
Trastuzumab, an epidermal growth factor receptor 2 (HER2) targeting humanized monoclonal antibody, has been approved for the treatment HER2-positive breast cancer and HER2-positve metastatic gastric cancer. However, cardiotoxicity associated with its clinical ... ...
